期刊文献+

2型糖尿病患者糖化血清白蛋白水平临床意义及影响因素 被引量:7

Clinical significance and influential factors of glycated albumin in patients with type 2 diabetes mellitus
原文传递
导出
摘要 目的评价糖化血清白蛋白(glycated albumin,GA)作为反映住院患者短期血糖控制及变化指标的可靠性。方法301例2型糖尿病患者,检测并比较入院第1天和住院第12天空腹血糖(fasting plasma glucose,FPG)、餐后2h血糖(2-hour postprandial plasma glucose,2hPG),1d指尖血糖谱均值(mean amplitude of glucose,MBG)、糖化血红蛋白(glycosylated hemoglobin,HbA1c)和GA值,分析GA与2hPG、MBG和HbA1c的相关性。结果 301例患者入院后第1天FPG水平为(11.85±8.33)mmol/L,2hPG为(15.43±5.48)mmol/L,MBG为(13.16±4.36)mmol/L,GA为(36.91±8.18)%,住院后第12天分别为(6.95±1.82)mmol/L、(9.27±2.48)mmol/L、(8.64±1.76)mmol/L、(25.66±7.35)%,差异有统计学意义(P<0.05);GA与2hPG(r=0.506,P=0.024)、MBG(r=0.744,P=0.040)及HbA1c(r=1.659,P=0.000)均呈正相关。结论 GA可准确、及时反映住院短期内血糖水平的变化,较HbA1c更适合作为评价2型糖尿病患者住院期间(12d)降糖疗效的临床监测指标。 Objective To assess the reliability of glycated albumin(GA)as a clinical marker for monitoring plasma glucose controlling in short term and its changes in inpatients with type 2diabetes mellitus(T2DM).Methods A total of301T2 DM inpatients were detected the changes of fasting plasma glucose(FPG),2-hour postprandial plasma glucose(2hPG),mean amplitude of glucosa(MBG),glycosylated hemoglobin(HbA1c)and GA levels on the 1st and 12 th days after admission respectively.Results The FPG level was(11.85±8.33)mmol/L,2hPG was(15.43±5.48)mmol/L,MBG was(13.16±4.36)mmol/L,and GA was(36.91±8.18)% on the 1st day after admission,significantly different from those on the 12 th day((6.95±1.82)mmol/L,(9.27±2.48)mmol/L,(8.64±1.76)mmol/L,(25.66±7.35)%)(P〈0.05).GA was positively correlated with 2hPG(r=0.506,P=0.024),MBG(r=0.744,P=0.040)and HbA1c(r=1.659,P=0.000).Conclusion GA can accurately and timely reflect the change of plasma glucose in short term,and is superior to HbA1 c for monitoring the plasma glucose controlling on the 12 th day after admission for T2 DM patients.
出处 《中华实用诊断与治疗杂志》 2015年第2期159-161,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 四川省卫生厅课题项目(110128)
关键词 2型糖尿病 糖化血清白蛋白 血糖 Type 2diabetes mellitus glycated albumin plasma glucose
  • 相关文献

参考文献12

  • 1American Diabetes Association. Standards of medical care in diabetes[J]. Diabetes Care,2004,27(Suppl 1) :S15-35.
  • 2Iberg N, Fluckiger R. Nonenzymatic glycosylation of albumin in vivo[J]. J Biol Chem, 1986,261(29) : 13542-13545.
  • 3Tahara Y, Shima K. Kinetics of HbAlc, glycated albumin, and fructosamine and analysis of their weight function against preceding plasma glucose level[J]. Diabetes Care, 1995,18 (4) 440-447.
  • 4A desktop guide to type 2 diabetes mellitus. European Diabetes Policy Group 1999[J]. Diabet Med,1999,16(9):716-730.
  • 5艾艳琴,邓华聪.糖化白蛋白与糖尿病[J].国际内分泌代谢杂志,2010,30(3):177-179. 被引量:14
  • 6顾燕云,邢慧莉,盛正妍,伍贻新,罗敏.酶法测定糖化血清白蛋白的多中心临床研究[J].上海医学,2006,29(7):432-434. 被引量:31
  • 7Takahashi S, Uchino H, Shimizu T, et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbAlc) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control[J]. Endocr J, 2007,54 (1) :139-144.
  • 8Shima K, Abe F, Hitota M, et al. High-performance liquid chromatographic assay of serum glycated albumin [ J ]. Diabetologia, 1988,31 (8) : 627-631.
  • 9Kouzuma T, Usami T, Yamakoshi M, et al. An enzymatic method for the measurement of glycated albumin in biological sample[J]. Clin Chim Acta,2002,324(1/2):61-71.
  • 10Zhang M, Kho AL, Anilkumar N, et al. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox 2 ( gp91phox )-containing NADPH oxidase[J]. Circulation, 2006,113(9) : 1235-1243.

二级参考文献35

共引文献48

同被引文献53

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部